drugset / Trial / NCT01549704

Effect of Adductor-Canal-Blockade on High Pain Responders After Total Knee Arthroplasty

NCT01549704 ↗

Phase 4 Completed 50 enrolled University Hospital, Gentofte, Copenhagen
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Adductor-Canal-Blockade (ACB) is superior to placebo when it comes to analgetic efficacy in high pain responders after Total Knee Arthroplasty (TKA). High pain responders are defined as patients reporting VAS \> 60 during knee flexion the 1. or 2. day after surgery.

Timeline

Start
2012-02
Primary completion
2012-12
Completion
2012-12

Outcome

Met primary endpoint

paper A 32-mm difference in VAS pain score, during active flexion of the knee (primary endpoint), was observed in favour of Group A, 95% confidence interval (CI): 23-42, P<0.0001. PMID 24401802 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 30 ml Other

Indications

No indication recorded.